个人中心 - 老虎社区

南山樵者

IP属地：江苏

帖子 · 23帖子 · 23
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 南山樵者南山樵者
  ·2021-07-14
  $Hepion Pharmaceuticals, Inc.(HEPA)$利好消息不会有诈吧？还是庄家没准备好？
  4,629 2
  2
  分享
  举报
- 南山樵者南山樵者
  ·2021-06-28
  $Hepion Pharmaceuticals, Inc.(HEPA)$这家研发的抗病毒药怎么样啦？会不会一飞冲天
  3,147 1
  点赞
  分享
  举报
- 南山樵者南山樵者
  ·2021-04-04
  $Hepion Pharmaceuticals, Inc.(HEPA)$搞个新药成功很不容易啊
  2,093 评论
  点赞
  分享
  举报
- 南山樵者南山樵者
  ·2021-04-04
  这是什么意思？
  BRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million
  April 2 (Reuters) - Hepion Pharmaceuticals Inc : * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF
  BRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million
  1,840 评论
  点赞
  分享
  举报
- 南山樵者南山樵者
  ·2021-02-16
  $Hepion Pharmaceuticals, Inc.(HEPA)$怎停牌啦？
  3,878 1
  点赞
  分享
  举报
- 南山樵者南山樵者
  ·2021-02-12
  $Infinity Pharmaceuticals(INFI)$投资者来来去去，我陪你五年啦！还会陪你走一段！
  1,558 评论
  点赞
  分享
  举报
- 南山樵者南山樵者
  ·2020-12-05
  $Hepion Pharmaceuticals, Inc.(HEPA)$现在入手等于买的原始股
  2,491 评论
  1
  分享
  举报
- 南山樵者南山樵者
  ·2020-08-24
  $Infinity Pharmaceuticals(INFI)$啥时来个撑杆跳
  2,534 评论
  点赞
  分享
  举报
- 南山樵者南山樵者
  ·2020-08-13
  $Infinity Pharmaceuticals(INFI)$好事将临，压不住了！
  2,635 评论
  点赞
  分享
  举报
- 南山樵者南山樵者
  ·2020-08-12
  $Infinity Pharmaceuticals(INFI)$量价齐升，好！
  2,571 评论
  点赞
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3448658753826017","uuid":"3448658753826017","gmtCreate":1485564733656,"gmtModify":1607138273514,"name":"南山樵者","pinyin":"nsqznanshanqiaozhe","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":56,"tweetSize":23,"questionSize":0,"limitLevel":900,"accountStatus":3,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"江苏","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":145262616,"gmtCreate":1626226065635,"gmtModify":1626226065635,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>利好消息不会有诈吧？还是庄家没准备好？","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>利好消息不会有诈吧？还是庄家没准备好？","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$利好消息不会有诈吧？还是庄家没准备好？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":1,"link":"https://laohu8.com/post/145262616","isVote":1,"tweetType":1,"viewCount":4629,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":127874239,"gmtCreate":1624844713621,"gmtModify":1624844713621,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>这家研发的抗病毒药怎么样啦？会不会一飞冲天","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>这家研发的抗病毒药怎么样啦？会不会一飞冲天","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$这家研发的抗病毒药怎么样啦？会不会一飞冲天","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/127874239","isVote":1,"tweetType":1,"viewCount":3147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":349310494,"gmtCreate":1617541064918,"gmtModify":1617541064918,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>搞个新药成功很不容易啊","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>搞个新药成功很不容易啊","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$搞个新药成功很不容易啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/349310494","isVote":1,"tweetType":1,"viewCount":2093,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":349310895,"gmtCreate":1617540992317,"gmtModify":1617540992317,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"这是什么意思？","listText":"这是什么意思？","text":"这是什么意思？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/349310895","repostId":"2124393756","repostType":2,"repost":{"id":"2124393756","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617391696,"share":"https://www.laohu8.com/m/news/2124393756?lang=&edition=full","pubTime":"2021-04-03 03:28","market":"us","language":"en","title":"BRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2124393756","media":"Reuters","summary":"April 2 (Reuters) - Hepion Pharmaceuticals Inc   :   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF ","content":"<html><body><p>April 2 (Reuters) - Hepion Pharmaceuticals Inc   :</p><p>   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF OF UP TO $350 MILLION - SEC FILING</p><p>Source text: () Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-03 03:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>April 2 (Reuters) - Hepion Pharmaceuticals Inc   :</p><p>   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF OF UP TO $350 MILLION - SEC FILING</p><p>Source text: () Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SANA":"Sana Biotechnology, Inc.","HEPA":"Hepion Pharmaceuticals, Inc.","CGEM":"Cullinan Therapeutics","LHDX":"Lucira Health, Inc.","LABP":"Landos Biopharma, Inc."},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2124393756","content_text":"April 2 (Reuters) - Hepion Pharmaceuticals Inc   :   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF OF UP TO $350 MILLION - SEC FILINGSource text: () Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":1840,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":382481873,"gmtCreate":1613475425092,"gmtModify":1613475425092,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>怎停牌啦？","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>怎停牌啦？","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$怎停牌啦？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/382481873","isVote":1,"tweetType":1,"viewCount":3878,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":388762092,"gmtCreate":1613098455916,"gmtModify":1613098455916,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>投资者来来去去，我陪你五年啦！还会陪你走一段！","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>投资者来来去去，我陪你五年啦！还会陪你走一段！","text":"$Infinity Pharmaceuticals(INFI)$投资者来来去去，我陪你五年啦！还会陪你走一段！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/388762092","isVote":1,"tweetType":1,"viewCount":1558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":396253278,"gmtCreate":1607134549794,"gmtModify":1703846671675,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>现在入手等于买的原始股","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>现在入手等于买的原始股","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$现在入手等于买的原始股","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/396253278","isVote":1,"tweetType":1,"viewCount":2491,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":979680777,"gmtCreate":1598226222199,"gmtModify":1704217974432,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>啥时来个撑杆跳","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>啥时来个撑杆跳","text":"$Infinity Pharmaceuticals(INFI)$啥时来个撑杆跳","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/979680777","isVote":1,"tweetType":1,"viewCount":2534,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":947868169,"gmtCreate":1597276491351,"gmtModify":1704215169161,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>好事将临，压不住了！","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>好事将临，压不住了！","text":"$Infinity Pharmaceuticals(INFI)$好事将临，压不住了！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/947868169","isVote":1,"tweetType":1,"viewCount":2635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":947978982,"gmtCreate":1597186013546,"gmtModify":1704214815359,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>量价齐升，好！","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>量价齐升，好！","text":"$Infinity Pharmaceuticals(INFI)$量价齐升，好！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/947978982","isVote":1,"tweetType":1,"viewCount":2571,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}